NeuroMetrix to debut wearable pain relief device at CES

• NeuroMetrix (NASDAQ:NURO -0.5%) will unveil its wearable non-invasive neuromostimulator for pain relief, Quell, at the Consumer Electronics Show January 6 - 9 in Las Vegas. It is FDA-approved and will be available without a prescription beginning in Q2. There will also be a smartphone app that will enable users to automatically track and personalize their pain therapy.